Acta Reumatologica Portuguesa is a premier open access journal dedicated to the field of rheumatology and general medicine, published by PUBLISAUDE-EDICOES MEDICAS LDA since its inception in 1973. Situated in Portugal, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that contribute to the understanding and management of rheumatic diseases. Despite its current Q4 ranking in both Medicine (miscellaneous) and Rheumatology, it serves as a vital platform for researchers and professionals aiming to share innovative insights and clinical practices within a rapidly evolving field. Researchers and medical professionals will find valuable information that can significantly influence their work, given the journal’s commitment to accessible knowledge through its open access model. By prioritizing collaboration and knowledge-sharing, Acta Reumatologica Portuguesa continues to engage with issues of critical relevance in rheumatology, appealing to a diverse audience of scholars and healthcare practitioners.

ZEITSCHRIFT FUR RHEUMATOLOGIE, published by Springer Heidelberg, serves as a vital platform in the field of rheumatology, providing researchers, clinicians, and students with cutting-edge findings and discussions related to the diagnosis, treatment, and management of rheumatic diseases. Since its inception in 1974 and continuing until 2024, this journal retains its commitment to disseminating significant scientific work within this specialized domain. Although it is currently categorized in the Q4 quartile for Rheumatology and ranks 47 out of 73 in Scopus, reflecting its burgeoning presence, the journal is dedicated to evolving and gaining prominence in the academic community. By offering valuable insights and fostering scholarly discourse, ZEITSCHRIFT FUR RHEUMATOLOGIE plays a crucial role in advancing rheumatology research and enhancing patient care practices worldwide. The journal presents an opportunity for its readers to engage with contemporary studies and enrich their understanding of rheumatic ailments.

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

ACR Open Rheumatology, published by WILEY, is a premier open-access journal dedicated to advancing the field of rheumatology. Since its inception in 2019, this journal has rapidly gained recognition, achieving a Q1 category ranking in the 2023 Scopus Quartiles, positioning it among the top 30% within its discipline. With a current Scopus rank of 22 out of 73 in Medicine - Rheumatology and an impressive 70th percentile, ACR Open Rheumatology serves as a vital platform for researchers and clinicians to disseminate knowledge on the latest developments in rheumatic diseases and treatments. The journal promotes unrestricted access to cutting-edge research, thus fostering collaboration and innovation in the rheumatological community. Situated in the United States, it caters to a global audience, encouraging submissions from researchers worldwide and addressing critical health issues that affect millions. We invite professionals, students, and researchers alike to engage with the transformative findings published in our journal.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.

JOURNAL OF RHEUMATOLOGY, published by the J Rheumatol Publ Co, stands as a distinguished platform within the fields of rheumatology and immunology since its inception in 1974. With an impressive impact evidenced by its 2023 rankings—Q1 in Rheumatology and Q2 in both Immunology and Allergy—the journal has secured its position as a vital resource for researchers and practitioners alike. The journal is dedicated to advancing clinical and experimental knowledge in the pathogenesis, diagnosis, and management of rheumatic diseases, providing a rich repository of peer-reviewed articles that drive innovation in treatment protocols and patient care. Although it operates under a subscription model, the journal remains accessible to a broad audience committed to advancing their understanding of these critical areas. Located in Toronto, Canada, it continues to attract contributions from leading experts globally, making it an essential read for anyone keen on staying at the forefront of rheumatological research and practice.

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

AKTUELLE RHEUMATOLOGIE is a prominent German journal published by GEORG THIEME VERLAG KG, dedicated to advancing the field of rheumatology. Since its inception in 1978, this peer-reviewed journal has been a vital resource for professionals, researchers, and students engaged in the study and treatment of rheumatic diseases. With an ISSN of 0341-051X and an E-ISSN of 1438-9940, the journal provides a platform for sharing groundbreaking research, clinical studies, and reviews. Although classified in the fourth quartile (Q4) of rheumatology journals and ranked 67 out of 73 in its category according to Scopus, AKTUELLE RHEUMATOLOGIE continues to contribute to the discourse in rheumatology. Its comprehensive coverage of recent advancements and innovative approaches makes it an essential publication for anyone interested in the latest developments in the field.